Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

SIMPLE SUMMARY: Management of chemorefractory colorectal cancer patient is challenging, and reliable tools which can predict individual patient prognosis and help the decision making are needed. In this study, we hypothesized that the natural pace of cancer growth and progression, as assessed by ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Camera, Silvia, Akin Telli, Tugba, Woff, Erwin, Vandeputte, Caroline, Kehagias, Pashalina, Guiot, Thomas, Critchi, Gabriela, Wissam, Yacine, Bregni, Giacomo, Trevisi, Elena, Pretta, Andrea, Senti, Chiara, Leduc, Sophia, Gkolfakis, Paraskevas, Hoerner, Frédéric, Rothé, Françoise, Sclafani, Francesco, Flamen, Patrick, Deleporte, Amelie, Hendlisz, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601470/
https://www.ncbi.nlm.nih.gov/pubmed/32987838
http://dx.doi.org/10.3390/cancers12102752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601470/
https://www.ncbi.nlm.nih.gov/pubmed/32987838
http://dx.doi.org/10.3390/cancers12102752

Ejemplares similares